GAMSITABART
UNII Q9DX3HXD25

Substance Identification & Data

This profile provides standardized clinical and technical data for Gamsitabart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q9DX3HXD25.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3040339-17-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
Q9DX3HXD25
CAS Registry Number
3040339-17-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
GAMSITABART
Official standardized name for this substance within the FDA UNII nomenclature system.
INN ID
13908
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gamsitabart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GAMSITABART

Common Names & Synonyms

GAMSITABART [INN]
HU14.18-IGG1.4(K322A)-DELK
IMMUNOGLOBULIN G1 (233-PROLINE,234-VALINE,235-ALANINE,322-ALANINE,330-SERINE,331-SERINE,DE-C-TERMINAL-LYSINE), ANTI-(GANGLIOSIDE GD2) (HUMAN MONOCLONAL MBE-91 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MBE-91 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS GD2 (DISIALOGANGLIOSIDE GD2)), MONOCLONAL ANTIBODY (GAMSITABART)

Technical Codes

MBE-91